Shanghai Bao Pharmaceuticals Co (HKSE:02659) FCF Margin %: -2,656.20% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02659 Shanghai Bao Pharmaceuticals Co Ltd HKSE:02659
9 GF Score
Price HK$15.94
! 2 Warning Signs
View Full Analysis

What is Shanghai Bao Pharmaceuticals Co FCF Margin %?

Shanghai Bao Pharmaceuticals Co HKSE:02659 +0.25% 9 FCF Margin % is -2,656.20% as of Dec. 2025. GuruFocus rates HKSE:02659 with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 956 Biotechnology companies, Shanghai Bao Pharmaceuticals Co ranks worse than 75.94% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Shanghai Bao Pharmaceuticals Co's Free Cash Flow for the six months ended in Dec. 2025 was HK$-210.27 Mil. Shanghai Bao Pharmaceuticals Co's Revenue for the six months ended in Dec. 2025 was HK$7.92 Mil. Therefore, Shanghai Bao Pharmaceuticals Co's FCF Margin % for the quarter that ended in Dec. 2025 was -2,656.20%.

As of today, Shanghai Bao Pharmaceuticals Co's current FCF Yield % is -7.09%.

The historical rank and industry rank for Shanghai Bao Pharmaceuticals Co's FCF Margin % or its related term are showing as below:

HKSE:02659' s FCF Margin % Range Over the Past 10 Years
Min: -5487.79   Med: -3990.96   Max: -678.27
Current: -681.35

During the past 3 years, the highest FCF Margin % of Shanghai Bao Pharmaceuticals Co was -678.27%. The lowest was -5487.79%. And the median was -3990.96%.

HKSE:02659's FCF Margin % is ranked worse than
75.94% of 956 companies
in the Biotechnology industry
Industry Median: -80.565 vs HKSE:02659: -681.35

Shanghai Bao Pharmaceuticals Co FCF Margin % Related Terms

Shanghai Bao Pharmaceuticals Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Shanghai Bao Pharmaceuticals Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bao Pharmaceuticals Co FCF Margin % Chart

Shanghai Bao Pharmaceuticals Co Annual Data
Trend Dec23 Dec24 Dec25
FCF Margin %
-3,990.96 -5,487.79 -678.27

Shanghai Bao Pharmaceuticals Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % 0.00 -15,582.99 -2,264.51 -340.75 -2,656.20

HKSE:02659 vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, Shanghai Bao Pharmaceuticals Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Bao Pharmaceuticals Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Bao Pharmaceuticals Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Bao Pharmaceuticals Co's FCF Margin % falls into.


HKSE:02659
9GF Score
Shanghai Bao Pharmaceuticals Co Ltd HKSE:02659
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Bao Pharmaceuticals Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Shanghai Bao Pharmaceuticals Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-368.33/54.304
=-678.27 %

Shanghai Bao Pharmaceuticals Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-210.265/7.916
=-2,656.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -2,656.20% mean?
Shanghai Bao Pharmaceuticals Co (HKSE:02659) has a FCF Margin % of -2,656.20% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Bao Pharmaceuticals Co and its competitors. According to the industry distribution chart, Shanghai Bao Pharmaceuticals Co ranks #726 out of 956 companies in the Biotechnology industry, placing it in the top 75.9%.
Is Shanghai Bao Pharmaceuticals Co's FCF Margin % too high?
Shanghai Bao Pharmaceuticals Co's current FCF Margin % is -2,656.20%. Based on the distribution chart, Shanghai Bao Pharmaceuticals Co ranks #726 out of 956 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shanghai Bao Pharmaceuticals Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Bao Pharmaceuticals Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Bao Pharmaceuticals Co ranks #726 out of 956 companies for FCF Margin %. This places Shanghai Bao Pharmaceuticals Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Bao Pharmaceuticals Co and its competitors. Shanghai Bao Pharmaceuticals Co's current FCF Margin % is -2,656.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Bao Pharmaceuticals Co stock overvalued right now?
Shanghai Bao Pharmaceuticals Co (HKSE:02659) has a current FCF Margin % of -2,656.20%. The current FCF Margin % is -2,656.20%. Shanghai Bao Pharmaceuticals Co's overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shanghai Bao Pharmaceuticals Co (HKSE:02659), the current FCF Margin % is -2,656.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Bao Pharmaceuticals Co Business Description

Address No. 28 Luoxin Road, Baoshan District, Shanghai, CHN
Shanghai Bao Pharmaceuticals Co Ltd is a biotechnology company with an approved product and a diverse clinical pipeline, leveraging synthetic biology technology to develop and deliver recombinant biologic drugs in China, targeting conditions with limited treatment options and complex manufacturing challenges. The company has proprietary technology platforms, supported by its chassis cell engineering technology, that combine drug design and bioprocessing capabilities. It has production lines for finished dosage forms, including injectable solutions, lyophilized powder injections, and pre-filled syringes. The group has only one reportable operating segment, which is the research, development, and commercialisation of pharmaceutical products.
9GF Score

Get the complete analysis for HKSE:02659

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$15.94
Price